--- title: Blog - Launch and Market Access trends in pharma | TRiBECA Knowledge | London | Andre Moa (2) description: Keep up to date with the latest launch, market access and tender management trends in the pharmaceutical and biotech sector. (2) --- ## Featured Post ### [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-author.png) Andre Moa - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-date.png) 21 Jan 2025 - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-length.png) 21 minute read Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good. [Read more](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) ## Latest posts ### [2022 New Drug Approvals: Review of New FDA and EMA Marketing Authorisations](https://www.tribecaknowledge.com/blog/2022-new-drug-approvals-review-of-new-fda-and-ema-marketing-authorisations) We look at how EU drug approvals hold firm in 2022, US lags and innovation flourishes [Read more](https://www.tribecaknowledge.com/blog/2022-new-drug-approvals-review-of-new-fda-and-ema-marketing-authorisations) ### [New Report: Launch Readiness 2022 - How to address key trends and challenges](https://www.tribecaknowledge.com/blog/new-report-launch-readiness-2022-how-to-address-key-trends-and-challenges) With COVID-19 driving innovation and agility, 2022 promises another rich crop of pharma launches. Closer cost-benefit scrutiny demands carefully differentiated value. [Read more](https://www.tribecaknowledge.com/blog/new-report-launch-readiness-2022-how-to-address-key-trends-and-challenges) ### [8 Pharma Trends for 2022: Towards a more holistic understanding of value](https://www.tribecaknowledge.com/blog/8-pharma-trends-for-2022-towards-a-more-holistic-understanding-of-value) Our 8 pharma trends for 2022 assess how new directions in the industry might lead to a more holistic conception of the value and benefit of drug innovation [Read more](https://www.tribecaknowledge.com/blog/8-pharma-trends-for-2022-towards-a-more-holistic-understanding-of-value) ### [2021 New Drug Approvals: Review of FDA and EMA Marketing Authorisations](https://www.tribecaknowledge.com/blog/2021-new-drug-approvals-review-of-new-fda-and-ema-marketing-authorisations) US and EU drug approvals have maintained their momentum in 2021, as another innovation bounty shows the sector is finding ways to work around COVID-19. [Read more](https://www.tribecaknowledge.com/blog/2021-new-drug-approvals-review-of-new-fda-and-ema-marketing-authorisations) ### [Agile launch execution requires the right digital tools](https://www.tribecaknowledge.com/blog/agile-launch-execution-requires-the-right-digital-tools) The right launch execution software is key to optimising pharmaceutical launches through agile ways of thinking and working. [Read more](https://www.tribecaknowledge.com/blog/agile-launch-execution-requires-the-right-digital-tools) ### [What Pfizer’s digital transformation strategy can teach us about making pharma more agile and effective](https://www.tribecaknowledge.com/blog/what-pfizers-digital-transformation-strategy-can-teach-us-about-making-pharma-more-agile-and-effective) The COVID-19 pandemic is a wake-up call for pharma to embed digital transformation at every level of its operations [Read more](https://www.tribecaknowledge.com/blog/what-pfizers-digital-transformation-strategy-can-teach-us-about-making-pharma-more-agile-and-effective) ### [How COVID-19 has accelerated digital transformation in pharma](https://www.tribecaknowledge.com/blog/how-covid-19-has-accelerated-digital-transformation-in-pharma) The COVID-19 pandemic is a wake-up call for pharma to embed digital transformation at every level of its operations [Read more](https://www.tribecaknowledge.com/blog/how-covid-19-has-accelerated-digital-transformation-in-pharma) ### [Product launches: making the most of your one shot](https://www.tribecaknowledge.com/blog/product-launches-making-the-most-of-your-one-shot) Pharma companies need a launch execution platform that makes launch excellence the norm and streamlines efforts to save time for everyone involved in product launches. [Read more](https://www.tribecaknowledge.com/blog/product-launches-making-the-most-of-your-one-shot) ### [Rethinking Launch Readiness in 2021: The New Normal in the Shadow of COVID](https://www.tribecaknowledge.com/blog/pre-and-post-covid-rethinking-launch-readiness-in-2021) COVID-19 has intensified launch challenges facing new drugs. R&D pipelines and regulatory approvals continue to deliver innovation and commercial promise. [Read more](https://www.tribecaknowledge.com/blog/pre-and-post-covid-rethinking-launch-readiness-in-2021) ### [5 Pharma Trends for 2021: Disruption and Transformation in the COVID Era](https://www.tribecaknowledge.com/blog/5-pharma-trends-for-2021-disruption-and-transformation-in-the-covid-era) The impact of COVID-19 threads through our 5 pharma trends for 2021, whether driving vaccine R&D or political change, hampering market access or accelerating digital transformation. [Read more](https://www.tribecaknowledge.com/blog/5-pharma-trends-for-2021-disruption-and-transformation-in-the-covid-era) ### [2020 New Drug Approvals: Review of New FDA and EMA Marketing Authorisations](https://www.tribecaknowledge.com/blog/2020-new-drug-approvals-and-updates-the-year-in-review) Despite the threat of pandemic disruption, US and EU drug approvals for 2020 are in good health, with breakthrough innovation much in evidence. [Read more](https://www.tribecaknowledge.com/blog/2020-new-drug-approvals-and-updates-the-year-in-review) ### [How the coronavirus crisis could affect your new drug launch](https://www.tribecaknowledge.com/blog/how-the-coronavirus-crisis-could-hit-your-new-drug-launch) The coronavirus is forcing pharma to think creatively about remote working in a constrained environment. Digital technology will be crucial in softening the pandemic’s multiple impacts on drug launches. [Read more](https://www.tribecaknowledge.com/blog/how-the-coronavirus-crisis-could-hit-your-new-drug-launch) ### Recent Posts - [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) - [Driving launch excellence with agile transformation](https://www.tribecaknowledge.com/blog/driving-launch-excellence-with-agile-transformation) - [Launch Readiness 2025: What this year holds in store for pharma product launches](https://www.tribecaknowledge.com/blog/launch-readiness-2025-what-this-year-holds-in-store-for-pharma-product-launches) - [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) ### Most Popular Posts - [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) - [What Pfizer’s digital transformation strategy can teach us about making pharma more agile and effective](https://www.tribecaknowledge.com/blog/what-pfizers-digital-transformation-strategy-can-teach-us-about-making-pharma-more-agile-and-effective) - [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) - [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - [Market Access 2025: Navigating the emerging HTA and drug reimbursement challenges](https://www.tribecaknowledge.com/blog/market-access-2025-new-report-on-navigating-the-emerging-hta-and-drug-reimbursement-challenges) ### Categories - [launch readiness](https://www.tribecaknowledge.com/blog/topic/launch-readiness) - [Market access](https://www.tribecaknowledge.com/blog/topic/market-access) - [Pharma trends](https://www.tribecaknowledge.com/blog/topic/pharma-trends) - [Pharma launch planning](https://www.tribecaknowledge.com/blog/topic/pharma-launch-planning) - [launch plan](https://www.tribecaknowledge.com/blog/topic/launch-plan) - [launch readiness framework](https://www.tribecaknowledge.com/blog/topic/launch-readiness-framework) - [launch effectiveness](https://www.tribecaknowledge.com/blog/topic/launch-effectiveness) - [launch strategy](https://www.tribecaknowledge.com/blog/topic/launch-strategy) - [Tender Management](https://www.tribecaknowledge.com/blog/topic/tender-management) #### Get our latest posts in your inbox TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.